Receptors involved in the positive inotropic action induced by dopamine on the ventricle of a 7-day-old chick embryo heart

Fundamental and Clinical Pharmacology

Volumn 12, Issue 2, 1998, Pages 133-142

  Ouedraogo, L ^a   Magnon, M ^b   Sawadogo, L ^a   Tricoche, R ^c  

^a UNIVERSITÉ DE OUAGADOUGOU   (France)

^b SANOFI   (France)

^c CNRS   (France)

Author keywords

Chick embryo heart ventricle; Dopaminergic receptors; Positive inotropic response; Post synaptic receptors; and adrenergic receptors

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; DOPAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; ISOPRENALINE; NORADRENALIN; PHENTOLAMINE; POSTSYNAPTIC RECEPTOR; PROPRANOLOL; TYRAMINE;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CHICK EMBRYO; CONTROLLED STUDY; ELECTROSTIMULATION; EMBRYO; HEART VENTRICLE; IN VITRO STUDY; INOTROPISM; NONHUMAN; PRIORITY JOURNAL;

EID: 0031968814     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1998.tb00933.x     Document Type: Article

References (42)

1. Amenta F, Gallo P, Rossodivita A, Ricci A. Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart. Naunyn-Schmiedeberg's Arch Pharmacol 1993 ; 347 : 147-54
2. Aronson, RS, Gelles JM. Electrophysiologic effects of dopamine on sheep cardiac purkinje fibers. J Pharmacol Exper Ther 1974 ; 188 : 596-604
3. Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R et al. β-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation ; 1990 ; 82 suppl I : I12-25
4. Brodde OE, Ini J, Motomura S, Schümann HJ. The mode of direct action of dopamine on the rabbit heart. J Cardiovasc Pharmacol 1980 ; 2 : 567-82
5. Canga L, Paroli L, Blank TJJ, Silver RB, Rifkind AB. 2, 3, 7, 8 tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. Mol Pharmacol 1993 ; 44 : 1142-51
6. Chesswilliams R, Austin CE, Obrien HL. a-adrenoceptors do not contribute to the chronotropic or inotropic responses of the avian heart to noradrenaline. J Auton Pharmacol 1991 ; 11 : 27-36
7. Civelli O, Bunzow JR, Grandy DK, Zhou Q-Y, Van Tol HM. Molecular biology of dopamine receptors. Eur J Pharmacol 1991 ; 207 : 277-86
8. Clark BJ. Dopamine receptors stimulants in hypertension. Acta Med Scand 1977 ; Suppl 606 : 95-9
9. Deighton NM, Motomura S, Bals S, Zerkowski HR, Bodde OE. Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine, and xamaterol in isolated human right atrium. J Pharmacol Exper Ther 1992 ; 262 : 532-8
10. Dougan DFH, Mearrick PT, Wade DN. Metoclopramide as a dopamine antagonist in the heart and gut of the mollusc tapes wathingi. Clin Exp Pharmacol Physiol 1974 ; 1 : 473-8
11. Einstein R, Barrett AM. A comparison of the cardiac action of dopamine and noradrenaline in anaesthetized dogs and guinea-pig atria. Clin Exp Pharmacol Physiol 1977 ; 4 : 143-51
12. Felder CC, Jose PA, Axelrod J. The dopamine-1 agonist, SKF82526 stimulates phospholipase C activity independent of adenylate cyclase. J Pharmacol Exp Ther 1989 ; 248 : 1-5
13. Gelles JM, Aronson RS. Voltage clamp analysis of the effects of dopamine on the transmembrane ionic currents underlying the action potential of sheep cardiac purkinje fibers. Circ Res 1977 ; 40 : 561-6
14. Goldberg LI. Cardiovascular and renal actions of dopamine, potential clinical applications. Pharmacol Rev 1972 ; 24 : 1-29
15. Goldberg LI, Kohli JD. Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system. Commun Psychopharmacol 1979 ; 3 : 447-56
16. Habuchi Y, Lu LL, Komori T, Okamoto S, Nishimura M, Morikawa J, Yoshimura M. Does dopamine act on myocardial cells? Hypertens Res 1995 ; 18 suppl I : S157-59
17. Hampton JR, Van Veldhuisen DJ, Kleber FX, Cowley A J, Adria, A, Block P et al. Randomised study of effect of ibopamine on survival in patient with advanced severe heart failure. Lancet 1997 ; 349 : 971-7
18. Higgins D, Pappano AJ. Developmental changes in the sensitivity of the chick embryo ventricle to b-adrenergic agonist during adrenergic innervation. Cir Res 1981 ; 48 : 245-53
19. Lokandwala MF, De Feo ML, Cavero I. Physiological and pharmacological significance of dopamine receptors in the cardiovascular system. In: Saito M, ed. Progress in hypertension, neurotransmitters as modulators of blood pressure. Utrecht: VNU International Science Press; 1988. p 115-44
20. Lokandwala MF, Amenta F. Anatomical distribution and function of dopamine receptors in the kidney. FASEB J 1991 ; 5 : 3023-30
21. Lokhandwala MF, Hegde SS. Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure. Am J Med 1991 ; 90 suppl 5B : 5B2S-9S
22. Massingham R, Dubocowich ML, Langer SZ. The role of presynaptic receptors in the cardiovascular actions of N, N-di-n-propyldopamine in the cat and dog. Naunyn-Schmiedeberg's Arch Pharmacol 1980 ; 314 : 17-28
23. Mubagwa K, Vites AM, Pappano AJ. Stimulant effects of muscarinic agonists in embryonic chick ventricular muscle, are the effects mediated by protein kinase C? J Pharmacol Exp Ther 1992 ; 260 : 1323-30
24. Mugelli A, Ledda F, Mantelli L, Torrini M, Maccioni T. Studies on the positive inotropic effect of dopamine in guinea-pig heart. Naunyn-Schmiedeberg's Arch Pharmacol 1977 ; 301 : 49-55
25. Ollagnier M, Lièvre M, Descotes J, Evreux J-C, Faucon G. Différence d'effets de la dopamine et de l'isoprénaline sur la conduction dans le noeud auriculoventriculaire. J Pharmacol 1979; 10(3): 173-84
26. Osnes SB, Oye I. Adenosine 3'5'-cyclic monophosphate in perfused rat hearts exposed to isoprenaline and dopamine. Acta Physiol Scand 1976 ; 96 : 100-13
27. Ouedraogo CO. Analyse electrophysiologique et pharmacologique comparée des propriétés cardiaques de quatre amines biogènes: adrénaline, dopamine, sérotonine et tryptamine. Thèse de doctorat ès Sciences Université Franÿois Rabelais de Tours; 1981
28. Ouedraogo L, Sawadogo L, Tricoche R. Effet inotrope de l'isoprénaline et de la noradrénaline sur le coeur embryonnaire de poulet. CR Acad Sd Paris 1997 ; 320 : 307-13
29. Pappano AJ. Ontogenetic development of autonomic neuro effectors transmission and transmitter reactivity in embryonic and foetal hearts. Pharmacol Rev 1977 ; 29 : 3-33
30. Port JD, Gilbert EM, Larrabee P, Mealey P, Volkman K, Ginsburg R et al. Neurotransmitter depletion compromise the ability of indirect-acting amines to provide inotropic support in the failing human heart. Circulation 1990 ; 81 : 929-38
31. Rajfer SIMD, Davis FRRN. Role of dopamine receptors and the utility of dopamine agonists in heart failure. Circulation 1990 ; 82 suppl I : I-97-102
32. Romanoff AL. The avion embryo: structural and functional development. New York: Mac Millan Co; 1960
33. Sandrini M, Benelli A, Baraldi M. Regulatory effect of calcium on 3H-dopamine binding to guinea-pig heart membrane preparations. Pharmacol Res Commun 1985 ; 17 : 991-1003
34. Shigenobu K, Sperelakis N. Calcium current channels induced by catecholamines in chick embryonic heart whose fast sodium channels are blocked by tetrodotoxin or elevated potassium. Circ Res 1972 ; 31 : 932-52
35. Sibley DR, Monsma FJ Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992 ; 13 ; 61-9
36. Sokoloff P, Martres MP, Schwartz JC. La famille des récepteurs de la dopamine. M/S 1993 ; 9 : 12-20
37. Steinfath M, Geertz B, Schmitz W, Scholz H, Haverich A, Breil I et al. Distinct down-regulation of cardiac b1- and b2-adrenoceptors in different human heart deseases. Naunyn-Schmiedeberg's Arch Pharmacol 1991 ; 343 : 217-20
38. Sunahara RK, Seeman P, Van Tol HHM, Niznik HB. Dopamine receptors and antipsychotic drug response. Br J Psychiat 1993 ; 163 suppl 22 : 31-8
39. Taylor SH. Prospects in heart failure: attractions of the concept of vasodilatation by dopaminergic stimulation. Am J Noninvas Cardiol 1991 ; 5 suppl 1 : 2-5
40. Tritthart H, Volkmann R, Weiss R, Eibach H. The interrelationship of calcium mediated action potentials, and tension development in cat ventricular myocardium. J Mol Cell Cardiol 1976 ; 8 : 249-61
41. Tsai TH, Langer SZ, Trendelenburg Cl. Effect of dopamine and a-methyldopamine on smooth muscle and on the cardiac pacemaker. J Pharmacol Exp Ther 1967 ; 156 : 310-24
42. Watanabe AM, Besch HR. Cyclic adenosine monophosphate modulation of slow calcium influx channels in guinea pig heart. Circ Res 1974 ; 35 : 316-24